J9298 Injection nivol relatlimab 3mg/1mg
J-Codes
Also known as: nivolumab relatlimab, Opdualag
Injection of nivolumab combined with relatlimab, 3 milligram and 1 milligram respectively. Dual checkpoint inhibitor combination therapy.
Clinical Context
First-line therapy for metastatic melanoma. Combines PD-1 and lymphocyte activation gene-3 (LAG-3) inhibition for enhanced immune response.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.